Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
ETF What's Up
Don’t Miss a Move in the ETF Market
Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.
266420 ETF · Samsung KODEX Healthcare ETF
The 266420 Exchange Traded Fund (ETF) is provided by Samsung Asset Management. It is built to track an index: Korea KRX Health Care Index. The 266420 ETF provides physical exposure, so by buying it you actually own parts of all the 62 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 12:00 AM UTC
LIVE
CLOSED
This fund is part ofAPAC Blended Cap1M perf.-5.35%
Last price
₩23,140
1M perf.
-3.30%
1M flows
-€4.5M
AuM
€57M
E/R
0.45%
Rating
Not rated
ESG Consensus®
266420
₩23,140
Performance & flows
Segment for quartile rank
December 11, 2025 → March 11, 2026
Create a free account to view the flows graph
266420
₩22,974.39
+4.89%
APAC Blended Cap
+9.55%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -3.30%  | +4.89%  | +33.33% | +105.20%  | +21.53% | -9.34% | +5.80% | +5.80% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
Issuer
ISIN
KR7266420009
AuM
€57M
E/R
0.45%
Replication rating
Not rated
ESG Consensus®
More details
NAV
3/11/2026
₩22,974.39
1D NAV change
-2.30%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
62
Inception date
3/27/2017
Jurisdiction
South Korea
Distribution
South Korea
Legal structure
Open-end Investment Trust
Base currency
KRW
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
KODEX Healthcare ETF invests in KRX Healthcare Sector which represents the leading companies in Healthcare industry sector covering KOSPI and KOSDAQ market.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
143860
1M perf.
-3.74%
E/R
0.4%
253280
1M perf.
-3.01%
E/R
0.4%
0056
1M perf.
-0.33%
E/R
0.435%
069500
1M perf.
+5.99%
E/R
0.15%
NAFTRACISHRS
1M perf.
-8.06%
E/R
0.25%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +4.89% | +33.33% | +105.20% | +21.53% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
Republic of Korea
96.95%
Unavailable
3.06%
Sectors
Health Care
87.00%
Consumer Discretionary
4.16%
Unavailable
8.85%
Diversification
Total weight of top 15 holdings out of 62
Top 15 holdings
Data as of January 31, 2026
CELLTRION
SAMSUNG BIOLOGICS CO LTD
ALTEOGEN INC
ABL BIO
HLB
YUHAN
PEPTRON
SAM CHUN DANG PH
Create a free account to view top holdings
LEGOCHEM BIOSCIENCES
KR70126Z0002
SK BIOPHARMACEUTICALS CO LTD
PHARMARESEARCH CO LTD
KR7347850000
HANMI PHARM
MEZZION PHARMA CO LTD
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about 266420 ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
266420’s has a Final Sustainability Grade of either B+, B, or B-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
78.01% of holdings have positive scoring
25.15% of holdings have negative scoring
13.88%
25.43%
38.69%
20.98%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Not rated
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
Korea KRX Health Care Index - KRW
Index ticker
KRXHLTH Index
Index dividend policy
PI
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Samsung Asset Management
Samsung Asset Management ID Card
Number of funds
145
Total AuM
€58.24B
Expense ratio range
0.015% - 2.28%
Average expense ratio
0.3679%
Top 5 funds by Samsung Asset Management
| AuM | ||
|---|---|---|
069500 | Samsung KODEX 200 ETF | €10.53B |
379800 | KODEX S&P500 TR | €4.76B |
459580 | Samsung Kodex CD Rate Active(SYNTH) ETF | €4.74B |
229200 | Samsung KODEX KOSDAQ 150 ETF | €4.29B |
278530 | Samsung KODEX 200 Total Return ETF | €3.33B |
Frequently asked questions about 266420
What does Samsung KODEX Healthcare ETF, 266420, invest in?
266420 is a Passive ETF. This ETF provides exposure to South Korean Health Care Equities.
Which benchmark or index does 266420 replicate?
266420 tracks the Korea KRX Health Care Index - KRW, through a full replication replication method.
What is the Total Expense ratio (TER) of 266420?
266420 carries a total expense ratio (TER) of 0.45%, indicating the annual cost for holding the fund.
When was 266420 launched?
266420 was introduced to the market on March 27, 2017. It trades on South Korea
Who is the ETF issuer of 266420?
Samsung KODEX Healthcare ETF, 266420, is provided by Samsung Asset Management. Learn more about Samsung Asset Management here.
What is the current assets under management (AUM) of 266420?
266420 oversees €57M in assets as of March 11, 2026.
How has 266420 performed lately?
Based on data from March 11, 2026, 266420 returned -3.30% over the past month, 4.89% over the last three months and 5.80% year-to-date.
What are the latest inflows or outflows for 266420?
As of March 11, 2026, 266420 recorded net flows of -€4.4M over the last month and -€6.8M year-to-date.
Does 266420 distribute dividends?
266420 follows a distributing dividend policy, meaning it pays out income to investors. As of March 11, 2026, its 12-month trailing yield was 0.19%.
What are the main country or region exposures of 266420?
As of January 31, 2026, 266420 has significant geographic allocations in Republic of Korea.
In which sector or theme does 266420 invest in?
As of January 31, 2026, 266420 focuses largely on Health Care and Consumer Discretionary.
How many securities does 266420 hold and how diversified is it?
As of January 31, 2026, 266420 holds 62 positions in its portfolio, with 74.82% of assets concentrated in its top 15 holdings.
What are the main positions in 266420?
As of January 31, 2026, 266420 top three holdings include CELLTRION, SAMSUNG BIOLOGICS CO LTD and ALTEOGEN INC.
What is the base currency of 266420?
The base currency of 266420 is KRW.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
